HiMedia, a leader in laboratory solutions, is spearheading a revolution in nucleic acid extraction across various industries through its Molecular Biology & Virology Division (HiGenoMB). The division's automated DNA/RNA extraction systems, notably the Insta NX® Mag24, are designed to address the limitations of conventional methods, offering high-quality, efficient, and reliable extraction.

The Insta NX Series of Magnetic Automated Extraction, including the Mag16, Mag32, and Mag96 models, caters to different sample processing capacities. The Mag24 model is specifically tailored for handling higher sample volumes of up to 5 ml per sample, making it particularly beneficial for oncology testing.

Moreover, the Mag24's versatility extends to applications beyond oncology, including automated midiprep plasmid DNA extractions for research and vaccine industries, agricultural screening for infections, and food diagnostics. The system's adaptability across industries is facilitated by unique kits designed for handling bulk samples effectively.

By employing magnetic bead-based systems, HiGenoMB-HiMedia ensures specificity and sensitivity in DNA extraction, significantly reducing manual errors and saving time compared to conventional methods. Furthermore, the company's user-friendly, pre-filled cartridges streamline workflow, enhancing laboratory efficiency.

In light of the COVID-19 pandemic, HiGenoMB-HiMedia's systems have played a crucial role in rapid pathogen detection. The company's patented process enables the processing of up to 96 COVID samples in approximately 11 minutes, contributing significantly to COVID testing efforts in India and abroad.

Looking ahead, HiGenoMB-HiMedia envisions further advancements in automated nucleic acid extraction technology, aiming to improve the accuracy and efficiency of diagnostic processes. By developing affordable Point-of-Care Testing (POCT) platforms and diagnostic kits, the company seeks to democratize access to advanced diagnostic tests, particularly in developing countries.

With its commitment to innovation and tailored solutions, HiGenoMB-HiMedia is poised to continue driving progress in molecular diagnostics across clinical, environmental, and food safety fields, fostering a better understanding and management of diseases globally.

HiMedia, a leader in laboratory solutions, is spearheading a revolution in nucleic acid extraction across various industries through its Molecular Biology & Virology Division (HiGenoMB).